Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review

Chronic lymphocytic leukemia (CLL) incidence increases with age reaching 37.9/100,000 in patients over 85 years. Although there is no standardized geriatric tool specifically validated for CLL, a correct framing of the fitness status is of critical importance to individualize treatment strategies. B...

Descripción completa

Detalles Bibliográficos
Autores principales: Fresa, Alberto, Autore, Francesco, Galli, Eugenio, Tomasso, Annamaria, Stirparo, Luca, Innocenti, Idanna, Laurenti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584288/
https://www.ncbi.nlm.nih.gov/pubmed/34768624
http://dx.doi.org/10.3390/jcm10215104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584288/
https://www.ncbi.nlm.nih.gov/pubmed/34768624
http://dx.doi.org/10.3390/jcm10215104

Ejemplares similares